Literature DB >> 16910780

The biphasic nature of nitric oxide responses in tumor biology.

Lisa A Ridnour1, Douglas D Thomas, Sonia Donzelli, Michael G Espey, David D Roberts, David A Wink, Jeffrey S Isenberg.   

Abstract

The dual or biphasic responses of cancer to nitric oxide (NO) arise from its concentration dependent ability to regulate tumor growth, migration, invasion, survival, angiogenesis, and metastasis. The outcome of these various NO-dependent processes is dictated by several factors including NO flux, the chemical redox environment, and the duration of NO exposure. Further, it was recently discovered that an NO-induced redox flux in vascular endothelial cells hypersensitizes these cells to the antiangiogenic effects of thrombospondin-1. This suggests a novel treatment paradigm for targeting tumor-driven angiogenesis that combines redox modulation with mimetic derivatives of thrombospondin-1. This article discusses the biphasic nature of NO in cancer biology and the implications of NO-driven redox flux for modulation of tumor-stimulated angiogenesis, growth, and metastasis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16910780     DOI: 10.1089/ars.2006.8.1329

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  72 in total

1.  S-nitrosylation regulates nuclear translocation of chloride intracellular channel protein CLIC4.

Authors:  Mariam Malik; Anjali Shukla; Palak Amin; Wendy Niedelman; Jessica Lee; Kasey Jividen; Juanita M Phang; Jinhui Ding; Kwang S Suh; Paul M G Curmi; Stuart H Yuspa
Journal:  J Biol Chem       Date:  2010-05-26       Impact factor: 5.157

Review 2.  Gene expression profiles of NO- and HNO-donor treated breast cancer cells: insights into tumor response and resistance pathways.

Authors:  Robert Y S Cheng; Debashree Basudhar; Lisa A Ridnour; Julie L Heinecke; Aparna H Kesarwala; Sharon Glynn; Christopher H Switzer; Stefan Ambs; Katrina M Miranda; David A Wink
Journal:  Nitric Oxide       Date:  2014-08-19       Impact factor: 4.427

Review 3.  CD47: a new target in cardiovascular therapy.

Authors:  Jeff S Isenberg; David D Roberts; William A Frazier
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-01-10       Impact factor: 8.311

Review 4.  Molecular regulation of tumor angiogenesis and perfusion via redox signaling.

Authors:  Thomas W Miller; Jeff S Isenberg; David D Roberts
Journal:  Chem Rev       Date:  2009-07       Impact factor: 60.622

Review 5.  Molecular pathways: inflammation-associated nitric-oxide production as a cancer-supporting redox mechanism and a potential therapeutic target.

Authors:  Elizabeth A Grimm; Andrew G Sikora; Suhendan Ekmekcioglu
Journal:  Clin Cancer Res       Date:  2013-07-18       Impact factor: 12.531

6.  Maintenance of androgen receptor inactivation by S-nitrosylation.

Authors:  Yu Qin; Anindya Dey; Hamsa Thayele Purayil; Yehia Daaka
Journal:  Cancer Res       Date:  2013-10-11       Impact factor: 12.701

7.  Differential effects of nitric oxide on blood-brain barrier integrity and cerebral blood flow in intracerebral C6 gliomas.

Authors:  Astrid Weyerbrock; Stuart Walbridge; Joseph E Saavedra; Larry K Keefer; Edward H Oldfield
Journal:  Neuro Oncol       Date:  2010-11-01       Impact factor: 12.300

8.  Inhibition of endothelial nitric oxide synthase decreases breast cancer cell MDA-MB-231 adhesion to intact microvessels under physiological flows.

Authors:  Lin Zhang; Min Zeng; Bingmei M Fu
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-04-08       Impact factor: 4.733

Review 9.  The dichotomous role of H2S in cancer cell biology? Déjà vu all over again.

Authors:  Khosrow Kashfi
Journal:  Biochem Pharmacol       Date:  2018-02-14       Impact factor: 5.858

Review 10.  Nitric Oxide-Mediated Resistance to Antitumor Photodynamic Therapy.

Authors:  Albert W Girotti
Journal:  Photochem Photobiol       Date:  2019-11-07       Impact factor: 3.421

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.